Stay updated on TOOKAD® Soluble vs Active Surveillance in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the TOOKAD® Soluble vs Active Surveillance in Prostate Cancer Clinical Trial page.

Latest updates to the TOOKAD® Soluble vs Active Surveillance in Prostate Cancer Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check18 days agoChange DetectedThe site revision shown in the footer changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedThe 403 Forbidden page remains unchanged, while the footer revision identifier updates from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check46 days agoChange DetectedThe study results page now shows a 403 Forbidden error, replacing the previous content. This blocks access to results, publications, and other study details.SummaryDifference7%

- Check68 days agoChange DetectedA new revision tag v3.6.6 is now displayed on the page, replacing the previous v3.6.5 tag. This indicates a frontend revision update rather than any substantive change to study information or layout.SummaryDifference0.1%

Stay in the know with updates to TOOKAD® Soluble vs Active Surveillance in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TOOKAD® Soluble vs Active Surveillance in Prostate Cancer Clinical Trial page.